A new perspective on vitamin B12 deficiency in rheumatology: a case-based review

Rheumatol Int. 2024 Apr;44(4):737-741. doi: 10.1007/s00296-024-05539-y. Epub 2024 Jan 31.

Abstract

Vitamin B12 (cobalamin) deficiency is common in patients with rheumatic diseases. Pernicious anemia is a well-known cause, but recent reports suggest that autoimmune-derived deficiency may not be limited to this cause alone. Symptoms of low vitamin B12 concentration are often deceptive, mimicking and overlapping with symptoms of other conditions. Neuropsychiatric manifestations, anemia, and fatigue are frequently attributed to a rheumatic disease without further evaluation. In this study, we present three cases of patients with neuropathic pain, depression, fatigue, and muscle weakness, initially attributed to a rheumatic disease, which almost completely resolved after implementing vitamin B12 supplementation. Furthermore, we provide an overview of current scientific reports regarding the potential use of cobalamin in rheumatology. Treatment of pain and neuropathy, often very challenging in long-lasting rheumatic diseases, can be more effective after a course of vitamin B12, even when no apparent deficiency is detected in laboratory tests. Considering recent research demonstrating vitamin B12's nerve-protecting properties, we recommend that physicians should assess vitamin B12 levels early in the diagnostic process of rheumatic diseases. In specific cases, physicians should consider cobalamin supplementation regardless of vitamin B12 serum concentration.

Keywords: Dietary supplements; Polyneuropathies; Vitamin B12; Vitamin B12 deficiency.

Publication types

  • Review

MeSH terms

  • Humans
  • Rheumatic Diseases* / complications
  • Rheumatic Diseases* / diagnosis
  • Rheumatic Diseases* / drug therapy
  • Rheumatology*
  • Vitamin B 12 / therapeutic use
  • Vitamin B 12 Deficiency* / complications
  • Vitamin B 12 Deficiency* / diagnosis
  • Vitamin B 12 Deficiency* / drug therapy

Substances

  • Vitamin B 12